Rucaparib poly ADP-ribose polymerase (PARP) inhibitor

PF-01367338 - AG-014699 - AG014699 - AG 014699 - rucaparib



Trial Studied treatment Control Patients Size Study type Results NCT

Ovarian cancer - poly ADP-ribose polymerase (PARP) inhibitor in all type of patient (BRCA mutated or not)

ARIEL 4 ongoing rucaparibchemotherapyRelapsed BRCA MutantNA Confirmatory - NCT02855944
ARIEL 3 ongoing rucaparibplaceboNA Confirmatory NCT01968213



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons